Antiviral restriction factor transgenesis in the domestic cat

42Citations
Citations of this article
264Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Studies of the domestic cat have contributed to many scientific advances, including the present understanding of the mammalian cerebral cortex. A practical capability for cat transgenesis is needed to realize the distinctive potential of research on this neurobehaviorally complex, accessible species for advancing human and feline health. For example, humans and cats are afflicted with pandemic AIDS lentiviruses that are susceptible to species-specific restriction factors. Here we introduced genes encoding such a factor, rhesus macaque TRIMCyp, and eGFP, into the cat germline. The method establishes gamete-targeted transgenesis for the first time in a carnivore. We observed uniformly transgenic outcomes, widespread expression, no mosaicism and no F1 silencing. TRIMCyp transgenic cat lymphocytes resisted feline immunodeficiency virus replication. This capability to experimentally manipulate the genome of an AIDS-susceptible species can be used to test the potential of restriction factors for HIV gene therapy and to build models of other infectious and noninfectious diseases. © 2011 Nature America, Inc. All rights reserved.

Cite

CITATION STYLE

APA

Wongsrikeao, P., Saenz, D., Rinkoski, T., Otoi, T., & Poeschla, E. (2011). Antiviral restriction factor transgenesis in the domestic cat. Nature Methods, 8(10), 853–859. https://doi.org/10.1038/nmeth.1703

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free